F/m Emerald Life Sciences Innovation ETF LFSC
46.40 USD +1.56 (+3.48%)
Nov 9, 2026, 11:51 AM EST
46.38 Day range 46.38
32.84 52-week range 48.78
- YTD
- +26.71%
- 1 year
- +46.88%
News
benzinga.com Spyre Therapeutics Breaks Higher On Positive Data From Ulcerative Colitis Drug Spyre Therapeutics stock jumps after Phase 2 SKYLINE data; SPY001 shows efficacy in ulcerative colitis as analysts maintain bullish outlook.
benzinga.com Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application FDA accepts Cogent Biosciences' NDA for bezuclastinib in NonAdvSM. PDUFA date set for Dec 30, 2026. COGT stock rises on the news.
benzinga.com FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer FDA approves Guardant Health's blood test to help identify metastatic colorectal cancer patients eligible for targeted treatment.
benzinga.com Travere Stock Slips After FDA Delays Review Of Key Kidney Drug Travere Therapeutics' stock declines as FDA extends review of key kidney drug. Q4 sales forecast at $127 million.
benzinga.com This New ETF Doesn't Wait For Stability — It Profits From Disruption This ETF dives into overlooked corners of the market, betting on catalysts such as M&A, regulatory shifts and corporate turnarounds.